Antifungal effect of ophthalmic preservatives phenylmercuric nitrate and benzalkonium chloride on ocular pathogenic filamentous fungi

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 1, 2013, Pages 64-67

  Xu, Yan ^a   He, Yi ^a   Li, Xiaohua ^b   Gao, Chuanwen ^a   Zhou, Lutan ^a   Sun, Shengtao ^a   Pang, Guangren ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Department of Ophthalmology   (China)

Author keywords

Alternaria alternata; Antifungal activity; Aspergillus spp.; Benzalkonium chloride; Filamentous fungi; Fungal keratitis; Fusarium spp.; Phenylmercuric nitrate; Susceptibility

Indexed keywords

AGENTS ACTING ON THE EYE; BENZALKONIUM CHLORIDE; KETOCONAZOLE; NATAMYCIN; PHENYLMERCURIC NITRATE; PRESERVATIVE;

ALTERNARIA ALTERNATA; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS VERSICOLOR; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FILAMENTOUS FUNGUS; FUNGUS; FUSARIUM; FUSARIUM MONILIFORME; FUSARIUM OXYSPORUM; FUSARIUM SOLANI; IN VITRO STUDY; KERATOMYCOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ALTERNARIA; ANTIFUNGAL AGENTS; ASPERGILLUS; BENZALKONIUM COMPOUNDS; FUSARIUM; HUMANS; KERATITIS; MICROBIAL SENSITIVITY TESTS; OPHTHALMIC SOLUTIONS; PHENYLMERCURY COMPOUNDS; PRESERVATIVES, PHARMACEUTICAL;

EID: 84870751030     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.09.008     Document Type: Article

References (25)

1. Baudouin C., Labbé A., Liang H., Pauly A., Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010, 29:312-334.
2. Debbasch C., Brignole F.O., Pisella P.J., Warnet J.M. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001, 42:642-652.
3. Garron L.K., Wood I.S., Spencer W.H., Hayes T.L. A clinical pathologic study of mercurialentis medicamentosus. Trans Am Ophthalmol Soc 1976, 76:295-320.
4. Iqbal N.J., Boey A., Park B.J., Brandt M.E. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis 2008, 62:348-350.
5. Lalitha P., Shapiro B.L., Srinivasan M., Prajna N.V., Acharya N.R., Fothergill A.W., Ruiz J., Chidambaram J.D., Maxey K.J., Hong K.C., McLeod S.D., Lietman T.M. Antimicrobial susceptibility of fusarium, aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol 2007, 125:789-793.
6. Lalitha P., Vijaykumar R., Prajna N.V., Fothergill A.W. In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder. J Clin Microbiol 2008, 46:3477-3478.
7. Mehta H., Mehta H.B., Garg P., Kodial H. Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis. Indian J Ophthalmol 2008, 56:243-245.
8. NCCLS Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A 2002, National Committee for Clinical Laboratory Standards, Wayne, PA.
9. O'Day D.M., Head W.S., Robinson R.D., Clanton J.A. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res 1986, 5:877-882.
10. Pradhan L., Sharma S., Nalamada S., Sahu S.K., Das S., Garg P. Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates. Indian J Ophthalmol 2011, 59:512-514.
11. Rao S., Madhavan H., Rao G., Padmanabhan P. Fluconazole in filamentous fungal keratitis. Cornea 1997, 16:64-71.
12. Rosenthal R.A., Buck S.L., Henry C.L., Schlech B.A. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system. J Ocul Pharmacol Ther 2006, 22:440-448.
13. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004, 15:321-327.
14. Sun X.G., Wang Z.X., Wang Z.Q., Luo S.Y., Li R. Ocular fungal isolates and antifungal susceptibility in northern China. Am J Ophthalmol 2007, 143:131-133.
15. Thomas P.A. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003, 16:730-797.
16. Wang, DL (2005). Medical mycology-guide to laboratory examination. Beijing: People's Medical Publishing House, pp 4-37, 264-374, 421-446.
17. Wu SX (2005). Identification manual of medical fungi. Beijing: Chinese Academy of Medical Sciences & Peking Union Medical College Press, pp 60-68, 164-272.
18. Xie L., Dong X., Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol 2001, 85:1070-1074.
19. Xie L., Zhai H. Penetrating keratoplasty for treatment of fungal keratitis with corneal perforation. Chin J Ophthalmol 2005, 41:1009-1013.
20. Xie L., Zhai H., Zhao J., Sun S., Shi W., Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol 2008, 146:260-265.
21. Xu Y., Pang G.R., Gao C.W., Zhao D.Q., Wang B.L., Zhou L.T., Sun S.T., Du L.X., Chen Z.J. Comparison of the activities of silver nitrate with those of three antifungal agents against ocular pathogenic fungi in vitro. Chin J Ophthalmol 2009, 45:730-735.
22. Xu Y., Pang G.R., Gao C.W., Zhao D.Q., Zhou L.T., Sun S.T., Wang B.L. In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi. Antimicrob Agents Chemother 2009, 53:1636-1638.
23. Xu Y., Pang G.R., Zhao D.Q., Gao C.W., Zhou L.T., Sun S.T., Wang B.L. In vitro activity of thimerosal against ocular pathogenic fungi. Antimicrob Agents Chemother 2010, 54:536-539.
24. Xu Y., Pang G.R., Zhao D.Q., Gao C.W., Zhou L.T., Sun S.T., Wang B.L., Chen Z.J. Activity of butenafine against ocular pathogenic filamentous fungi in vitro. Chin J Ophthalmol 2010, 46:38-42.
25. Zhong W.X., Sun S.Y., Zhao J., Shi W.Y., Xie L.X. Retrospective study of suppurative keratitis in 1054 patients. Chin J Ophthalmol 2007, 43:245-250.